MedPath

MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

HSA:12

Drug Approvals

REMLEAS HARD CAPSULES 40 MG

Approval Date
May 19, 2021
HSA

SYMVENU HARD CAPSULES 3MG

Approval Date
Jul 11, 2019
HSA

SYMVENU HARD CAPSULES 6MG

Approval Date
Jul 11, 2019
HSA

SYMVENU HARD CAPSULES 4.5MG

Approval Date
Jul 11, 2019
HSA

SYMVENU HARD CAPSULES 1.5MG

Approval Date
Jul 11, 2019
HSA

TANATRIL TABLETS 5 mg

Approval Date
Jan 6, 1999
HSA

TANATRIL TABLETS 10 mg

Approval Date
Jan 6, 1999
HSA

HERBESSER R200 CAPSULES 200 mg

Approval Date
Sep 29, 1998
HSA

HERBESSER R100 CAPSULES 100 mg

Approval Date
Sep 29, 1998
HSA

HERBESSER 90 SR CAPSULE 90 mg

Approval Date
Dec 20, 1991
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.